Interleukin 33 ameliorates disturbance of regulatory T cells in pulmonary sarcoidosis

2018 ◽  
Vol 64 ◽  
pp. 208-216 ◽  
Author(s):  
Bin Zhang ◽  
Fan Zhao ◽  
Huimin Mao ◽  
Wenyan Ma ◽  
Yang Zhang ◽  
...  
2019 ◽  
Vol 21 (3) ◽  
pp. 467-478
Author(s):  
I. V. Kudryavtsev ◽  
N. M. Lazareva ◽  
O. P. Baranova ◽  
A. S. Golovkin ◽  
D. V. Isakov ◽  
...  

Sarcoidosis is a disorder of unknown etiology characterized by development of necrosis-free epithelioid cell granulomas in various tissues. There are two main phenotypes of pulmonary sarcoidosis (PS): Lofgren’s syndrome (LS) is an acute form with favorable outcome, while non-Lofgren’s syndrome (nLS) is a chronic type of disease that can lead to pulmonary fibrosis in 20% of cases.Our study was aimed at investigating changes in the main cell-surface differentiation antigens on peripheral blood regulatory T cells (Tregs) from the patients with first diagnosed PS without treatment (LS, n = 11) and nLS (n = 46) compared to healthy volunteers (HC, n = 26).These indexes might be used as immunological markers for predicting severity of this disorder. Flow cytometry analysis of peripheral blood cell samples demonstrated that the nLS patients had decreased relative numbers of CD3+ cells vs healthy controls, as well as diminished CD3+CD4+ cells vs HC and LS patients. Furthermore, the relative and absolute Treg numbers were also decreased in nLS group vs HC (2.83% (2.47; 3.36) vs 3.33% (2.79; 3.84), p = 0.021), and 37 (29; 52) cells vs 50 (42; 65), p = 0.004, respectively) per one microliter of peripheral blood. Relative number of CD39-positive Тregs in chronic vs acute sarcoidosis patients was associated with 51.02% (38.20; 61.62) vs 48.64% (41.46; 63.72) that was significantly (p < 0.001 and p = 0.007, respectively) higher than in HC (39.52% (11.55; 46.34). We have found that “naïve” (CD45R0-CD62L+) Тregs did not significantly differ in percentage of CD39- and CD73-positive cells in all the groups tested. Moreover, CD45R0+CD62L+ Тregs in LS and nLS patients contained significantly more CD39-positive cells (69.66% (61.92; 79.34) and 67.62% (61.92; 79.34), respectively, compared to 47.55% (15.74; 65.32) in HC (p < 0.001 and p = 0.004, respectively). In case of CD45R0 + CD62LTregs able to exit from the circulation and migrate to the site of inflammation, an increased percentage of CD39-positive subset was noted only in patients with chronic sarcoidosis and HC (61.79% (55.12; 73.09) and 57.27% (16.03; 66.98), p = 0.006). Enhanced CD39 expression on Tregs seems to be related to chronic immune response, so that antigen elimination becomes impossible due to Treg overactivation, as shown in patients with sarcoidosis and some other chronic autoimmune and infectious disorders.


CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A1263
Author(s):  
Dipendra Mitra ◽  
Rinkee Kumari ◽  
Sushmita Chakraborty

2020 ◽  
Vol 21 (11) ◽  
pp. 1371-1383
Author(s):  
Lucas D. Faustino ◽  
Jason W. Griffith ◽  
Rod A. Rahimi ◽  
Keshav Nepal ◽  
Daniel L. Hamilos ◽  
...  

2020 ◽  
Vol 69 (8) ◽  
pp. 1461-1475 ◽  
Author(s):  
Andra Jevtovic ◽  
Jelena Pantic ◽  
Ivan Jovanovic ◽  
Marija Milovanovic ◽  
Ivan Stanojevic ◽  
...  

2014 ◽  
Vol 73 (Suppl 1) ◽  
pp. A28.1-A28 ◽  
Author(s):  
Jérôme Biton ◽  
Allan Thiolat ◽  
Sara Khaleghparast Athari ◽  
Delphine Lemeiter ◽  
Roxane Hervé ◽  
...  

2021 ◽  
Vol 22 (14) ◽  
pp. 7443
Author(s):  
Sumika Toyama ◽  
Catharina Sagita Moniaga ◽  
Susumu Nakae ◽  
Masaru Kurosawa ◽  
Hideoki Ogawa ◽  
...  

Regulatory T cells (Tregs) suppress immune responses and maintain immunological self-tolerance and homeostasis. We currently investigated relationships between skin barrier condition and Treg behavior using skin barrier-disrupted mice. Skin barrier disruption was induced by repeated topical application of 4% sodium dodecyl sulfate (SDS) on mice. The number of CD4+ forkhead box protein P3 (Foxp3)+ Tregs was higher in 4% SDS-treated skins than in controls. This increasing was correlated with the degree of acanthosis. The numbers of interleukin (IL)-10+ and transforming growth factor (TGF)-β+ Tregs also increased in 4% SDS-treated skins. Localization of IL-33 in keratinocytes shifted from nucleus to cytoplasm after skin barrier disruption. Notably, IL-33 promoted the migration of Tregs in chemotaxis assay. The skin infiltration of Tregs was cancelled in IL-33 neutralizing antibody-treated mice and IL-33 knockout mice. Thus, keratinocyte-derived IL-33 may induce Treg migration into barrier-disrupted skin to control the phase transition between healthy and inflammatory conditions.


2020 ◽  
Author(s):  
Elizabeth C. Halvorsen ◽  
S. Elizabeth Franks ◽  
Brennan J. Wadsworth ◽  
Bryant T. Harbourne ◽  
Rachel A. Cederberg ◽  
...  

Immunity ◽  
2016 ◽  
Vol 44 (2) ◽  
pp. 355-367 ◽  
Author(s):  
Wilson Kuswanto ◽  
Dalia Burzyn ◽  
Marisella Panduro ◽  
Kathy K. Wang ◽  
Young Charles Jang ◽  
...  

2019 ◽  
Author(s):  
Amy Li ◽  
Rebecca H. Herbst ◽  
David Canner ◽  
Jason M. Schenkel ◽  
Olivia C. Smith ◽  
...  

ABSTRACTRegulatory T cells (Tregs) can impair anti-tumor immune responses and are associated with poor prognosis in multiple cancer types. Tregs in human tumors span diverse transcriptional states distinct from those of peripheral Tregs, but their contribution to tumor development remains unknown. Here, we used single cell RNA-Seq to longitudinally profile conventional CD4+ T cells (Tconv) and Tregs in a genetic mouse model of lung adenocarcinoma. Tissue-infiltrating and peripheral CD4+ T cells differed, highlighting divergent pathways of activation during tumorigenesis. Longitudinal shifts in Treg heterogeneity suggested increased terminal differentiation and stabilization of an effector phenotype over time. In particular, effector Tregs had enhanced expression of the interleukin 33 receptor ST2. Treg-specific deletion of ST2 reduced effector Tregs, increased infiltration of CD8+ T cells into tumors, and decreased tumor burden. Our study shows that ST2 plays a critical role in Treg-mediated immunosuppression in cancer, highlighting new potential paths for therapeutic intervention.


Sign in / Sign up

Export Citation Format

Share Document